Metlife Stock News

Metropolitan Life Insurance Co NY grew its stake in FB Financial Co. (NYSE:FBK) by 105,566.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,510 shares of the financial services providers stock after purchasing an additional 9,501 shares during the period. []

Metropolitan Life Insurance Co NY lifted its position in MannKind Co. (NASDAQ:MNKD) by 145,008.9% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 65,299 shares of the biopharmaceutical companys stock after buying an additional 65,254 shares during the period. Metropolitan []

Metropolitan Life Insurance Co NY acquired a new position in Celldex Therapeutics, Inc. (NASDAQ:CLDX) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 11,107 shares of the biopharmaceutical companys stock, valued at approximately $371,000. Several other hedge funds also recently bought and sold []

Metropolitan Life Insurance Co NY lifted its position in TriMas Co. (NASDAQ:TRS) by 109,663.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,074 shares of the industrial products companys stock after acquiring an additional 12,063 shares during the []

Metropolitan Life Insurance Co NY increased its position in Southside Bancshares, Inc. (NASDAQ:SBSI) by 106,466.7% in the 2nd quarter, Holdings Channel reports. The firm owned 9,591 shares of the banks stock after buying an additional 9,582 shares during the period. Metropolitan Life Insurance Co NYs holdings in Southside Bancshares were worth $367,000 as of its []

Metropolitan Life Insurance Co NY boosted its position in Eventbrite, Inc. (NYSE:EB) by 111,429.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,960 shares of the companys stock after acquiring an additional 18,943 shares during the quarter. Metropolitan Life Insurance Co NYs holdings in []

Metropolitan Life Insurance Co NY grew its stake in The Greenbrier Companies, Inc. (NYSE:GBX) by 109,775.0% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 8,790 shares of the transportation companys stock after purchasing an additional 8,782 shares during the period. Metropolitan Life Insurance Co NYs holdings in Greenbrier Companies were worth $383,000 as []

Arden Trust Co grew its stake in shares of MetLife, Inc. (NYSE:MET) by 4.7% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 19,480 shares of the financial services providers stock after acquiring an additional 877 shares during the period. Arden Trust Cos holdings in MetLife were worth $1,203,000 at the end of the []

MetLife Investment Management LLC lowered its stake in shares of Diamond Hill Investment Group, Inc. (NASDAQ:DHIL) by 44.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 856 shares of the asset managers stock after selling 690 shares during the quarter. MetLife []

Metropolitan Life Insurance Co NY increased its position in OPKO Health, Inc. (NASDAQ:OPK) by 90,722.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 98,088 shares of the biotechnology companys stock after acquiring an additional 97,980 shares during the period. Metropolitan Life Insurance []

Metropolitan Life Insurance Co NY raised its position in shares of The RealReal, Inc. (NASDAQ:REAL) by 120,194.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,653 shares of the companys stock after buying an additional 21,635 shares during the period. Metropolitan []

Metropolitan Life Insurance Co NY increased its holdings in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) by 108,530.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 35,848 shares of the biopharmaceutical companys stock after purchasing an additional 35,815 shares during the quarter. Metropolitan Life []

Metropolitan Life Insurance Co NY boosted its position in SiTime Co. (NASDAQ:SITM) by 115,100.0% during the second quarter, Holdings Channel.com reports. The fund owned 3,456 shares of the companys stock after acquiring an additional 3,453 shares during the period. Metropolitan Life Insurance Co NYs holdings in SiTime were worth $437,000 at the end of the []

Metropolitan Life Insurance Co NY lifted its position in MacroGenics, Inc. (NASDAQ:MGNX) by 107,513.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,142 shares of the biopharmaceutical companys stock after acquiring an additional 16,127 shares during the quarter. Metropolitan Life []

MetLife Investment Management LLC grew its stake in shares of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) by 281.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,552 shares of the companys stock after acquiring an additional 10,736 shares during the period. MetLife []